The US based Pancreatic Cancer Action Network informs their members about Immunovia’s blood test IMMray™ PanCan-d
LUND, SWEDEN –Immunovia AB (publ) (“Immunovia”), a diagnostic company that develops and sells highly accurate blood tests for the early detection of cancer, today announced that the largest patient organization for pancreatic cancer in the US – Pancreatic Cancer Action Network (PanCAN) – informed their constituents about Immunovia, Inc.’s blood test IMMray™ PanCan-d on its website, in social media and through direct email contact. PanCAN underlines that IMMray™ PanCan-d is the first-ever blood test specific for